Skip to content

Use of nirgundi leaves on tinea infection

Standardization of Nirgundi ( Vitex negundo Linn.) and evaluation of its Anti-oxidant activity with special reference to Dadru ( Tinea infection ). - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079976
Enrollment
122
Registered
2025-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Dipti Gaurav Kadam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with classical lakshanas of Dadru 2.Patients of all varieties of Tinea will be selected without discriminating its area of infection. 3.Both fresh and treated cases of Dadru will be selected.

Exclusion criteria

Exclusion criteria: 1.Patients suffering with systemic disorders like uncontrolled Diabetes Mellitus,Auto-Immune diseases, HIV (Clinically diagnosed) will be excluded. 2.Tinea associated with other skin diseases will be exclud. 3.Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
treatment of fungal infectionTimepoint: baseline, 7days, 14 days,21 days

Secondary

MeasureTime frame
Detailed & Scientific study of Nirgundi Vitex negundo LinnTimepoint: baseline, 7days, 14 days,21 days

Countries

India

Contacts

Public ContactDr Jai Kini

Dr.G.D.Pol Foundations YMT Ayurvedic Medical College

drmanoj.kadam@gmail.com8767091736

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026